Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models

• Príomhchruthaitheoirí: Pinar Kanlikilicer (Údar), Bulent Ozpolat (Údar), Burcu Aslan (Údar), Recep Bayraktar (Údar), Nilgun Gurbuz (Údar), Cristian Rodriguez-Aguayo (Údar), Emine Bayraktar (Údar), Merve Denizli (Údar), Vianey Gonzalez-Villasana (Údar), Cristina Ivan (Údar), Ganesh L.R. Lokesh (Údar), Paola Amero (Údar), Silvia Catuogno (Údar), Monika Haemmerle (Údar), Sherry Yen-Yao Wu (Údar), Rahul Mitra (Údar), David G. Gorenstein (Údar), David E. Volk (Údar), Vittorio de Franciscis (Údar), Anil K. Sood (Údar), Gabriel Lopez-Berestein (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Elsevier, 2017-12-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Despite substantial improvements in the treatment strategies, ovarian cancer is still the most lethal gynecological malignancy. Identification of drug treatable therapeutic targets and their safe and effective targeting is critical to improve patient survival in ovarian cancer. AXL receptor tyrosine...